Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006071
Filing Date
2018-05-01
Accepted
2018-05-01 15:05:16
Documents
32
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 183996
2 ex31-1.htm EX-31.1 11135
3 ex31-2.htm EX-31.2 11192
4 ex32-1.htm EX-32.1 5377
5 image_001.jpg GRAPHIC 3792
  Complete submission text file 0001493152-18-006071.txt   813250

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vapa-20180331.xml EX-101.INS 50279
7 XBRL SCHEMA FILE vapa-20180331.xsd EX-101.SCH 11748
8 XBRL CALCULATION FILE vapa-20180331_cal.xml EX-101.CAL 20658
9 XBRL DEFINITION FILE vapa-20180331_def.xml EX-101.DEF 29007
10 XBRL LABEL FILE vapa-20180331_lab.xml EX-101.LAB 87390
11 XBRL PRESENTATION FILE vapa-20180331_pre.xml EX-101.PRE 66739
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 18795062
SIC: 2834 Pharmaceutical Preparations